Dr Sheila Waiter stated that it was generally accepted that the benefits of Hemofil outweighed the risks of acquiring hepatitis B but that the statement that every lot of the product was probably contaminated with hepatitis B would be a surprise to clinicians especially as the practice of issuing warning labels was being discontinued by the manufacturer.

Chronology Information

Date:

Chapter/issue
Pharmaceutical Companies
Key Person(s)
Sir William Maycock